within Pharmacolibrary.Drugs.ATC.N;

model N05AX08
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 9.15e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013000000000000001,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.0017,
    k12             = 5.39,
    k21             = 5.39
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05AX08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Risperidone is an atypical antipsychotic medication primarily used to treat schizophrenia, bipolar disorder, and irritability associated with autism. It is an approved medication commonly used in psychiatric practice for both adults and children.</p><h4>Pharmacokinetics</h4><p>PK model parameters reported from healthy adult volunteers after single 2 mg oral dose.</p><h4>References</h4><ol><li><p>Correll, CU, et al., &amp; Saklad, SR (2021). Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. <i>CNS drugs</i> 35(1) 39–59. DOI:<a href=&quot;https://doi.org/10.1007/s40263-020-00779-5&quot;>10.1007/s40263-020-00779-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33507525/&quot;>https://pubmed.ncbi.nlm.nih.gov/33507525</a></p></li><li><p>Sutar, R, et al., &amp; Chaudhary, P (2021). Antipsychotics and hemodialysis: A systematic review. <i>Asian journal of psychiatry</i> 55 102484–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ajp.2020.102484&quot;>10.1016/j.ajp.2020.102484</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33341539/&quot;>https://pubmed.ncbi.nlm.nih.gov/33341539</a></p></li><li><p>Spanarello, S, &amp; La Ferla, T (2014). The pharmacokinetics of long-acting antipsychotic medications. <i>Current clinical pharmacology</i> 9(3) 310–317. DOI:<a href=&quot;https://doi.org/10.2174/15748847113089990051&quot;>10.2174/15748847113089990051</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23343447/&quot;>https://pubmed.ncbi.nlm.nih.gov/23343447</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05AX08;
